[ESBL--increasing resistance problems. Cephalosporins no longer obvious choice in diffuse infections]

Lakartidningen. 2007 Dec 19;104(51-52):3883-5.
[Article in Swedish]
No abstract available

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use*
  • Cephalosporins / therapeutic use*
  • Cross Infection / drug therapy*
  • Cross Infection / microbiology
  • Drug Resistance, Multiple, Bacterial
  • Enterobacteriaceae / drug effects
  • Enterobacteriaceae / enzymology
  • Enterobacteriaceae Infections / drug therapy*
  • Enterobacteriaceae Infections / microbiology
  • Escherichia coli Infections / drug therapy
  • Female
  • Humans
  • Klebsiella Infections / drug therapy
  • Male
  • Middle Aged
  • Risk Factors
  • Urinary Tract Infections / drug therapy
  • Urinary Tract Infections / microbiology
  • beta-Lactam Resistance*
  • beta-Lactamases / metabolism*

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • beta-Lactamases